GL1X · GenesisL1 explorer

MolNFT v1 · #126324 · protein

Fragment-based inhibitors of lipoprotein associated phospholipase A2

5LZ9 · Platelet-activating factor acetylhydrolase: “Fragment-based inhibitors of lipoprotein associated phospholipase A2”. X-ray diffraction, 3 ligands (7BR, NA, CL), 2 pockets (best druggability 0.58). MolNFT v1 #126324 on GenesisL1: 3D…

PDB
5LZ9
Type
protein
Length
370 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Platelet-activating factor acetylhydrolase
EC
3.1.1.47
UniProt
Q13093
Ligands
7BR, NA, CL
Pockets
2 · best druggability 0.58

Structure

x-ray diffraction · 1 distinct chain · 35% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APlatelet-activating factor acetylhydrolase (EC 3.1.1.47)protein37035% helix, 21% strandQ13093

Ligands and binding sites

  • 7BR · 2-fluoranyl-5-[2-[(4~{S})-4-[4-methyl-1,1-bis(oxidanylidene)thian-4-yl]-2-oxidanylidene-pyrrolidin-1-yl]ethoxy]benzenecarbonitrile · ligand · chains A
  • NA · Sodium ion · metal · chains A
  • CL · Chloride ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12330.580.78297BR
2690.310.7418empty

Compared structures

  • 5LZ9 · Fragment-based inhibitors of Lipoprotein associated Phospholipase A2 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q13093 · AlphaFold monomer V2.0 prediction for platelet-activating factor acetylhydrolase (Q13093) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.